Rossari Biotech has delayed its planned capacity expansion for at least two years, indicating an adaptive approach to the present market challenges. This move is aimed at maintaining strategic objectives.

Unitop Chemicals, a subsidiary of Rossari Biotech, has recently commissioned an ethoxylation capacity expansion of 15,000 MTPA, reaching halfway to their planned 30,000 MTPA expansion goal. By March 2026, Rossari Biotech's total manufacturing capacity will increase to 66,000 MTPA.